Brief: Anika Therapeutics Q1 Loss Per Share $0.20
05/05/2022 23:57
May 5 (Reuters) - Anika Therapeutics Inc ANIK.O :
* ANIKA REPORTS FIRST QUARTER FISCAL 2022 FINANCIAL RESULTS
* Q1 ADJUSTED LOSS PER SHARE $0.11
* Q1 LOSS PER SHARE $0.20
* Q1 REVENUE ROSE 7 PERCENT TO $36.7 MILLION
Source text for Eikon: ID:nGNXf7nPV
Further company coverage: ANIK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anika Therapeutics
See all newsAnika Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Anika Therapeutics Q2 revenue rises, lifts 2026 outlook
Anika Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing
Anika Therapeutics Q1 revenue rises 13%